Skip to Content

A/P 12.5/45 (Oseni 12.5 mg / 45 mg)

Generic Name: alogliptin/pioglitazone

Pill with imprint A/P 12.5/45 is Red, Round and has been identified as Oseni 12.5 mg / 45 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

Oseni is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 12.5 mg / 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A/P 12.5/45

Oseni

Generic Name
alogliptin/pioglitazone
Imprint
A/P 12.5/45
Strength
12.5 mg / 45 mg
Color
Red
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC)
64764-0124
Inactive Ingredients
mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), titanium dioxide, polyethylene glycol 8000, magnesium silicate, lactose monohydrate, ferric oxide red, carnauba wax, polyglyceryl-10 oleate, butyl alcohol, alcohol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "A/P 12.5/45"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.